Lobbying · Trade or business body
Association of the British Pharmaceutical Industry
Meetings with ministers
32
In the last 12 months
6
Different ministers
18
Lobbying firms used
1
Meetings with ministers
| Date | Minister | Purpose, as published |
|---|---|---|
| 17 June 2026 | Preet Kaur GillDHSC | Introductory stakeholder call |
| 6 March 2026 | Dr Zubir AhmedDHSC | To discuss the US-UK Pharmaceutical Agreement |
| 4 March 2026 | Jason StockwoodDBT | To discuss the UK life sciences commerical environment |
| 3 February 2026 | Dr Zubir AhmedDHSC | To discuss the National Cancer Plan |
| 6 January 2026 | Chris McDonaldDBT | Roundtable to discuss the British Industrial Cost Competitiveness scheme |
| 4 November 2025 | Patrick VallanceDSIT | To discuss the Life Sciences Sector |
| 16 September 2025 | Zubir AhmedDHSC | To discuss how to make the UK a global leader in clinical research and life sciences |
| 19 June 2025 | Jonathan ReynoldsDBT | To discuss the Industrial Strategy |
| 16 June 2025 | Patrick VallanceDSIT | To include various topics with inward investors including clinical trials, regulatory alignment and scientific collaboration. |
| 4 June 2025 | Poppy GustafssonDBT | To discuss the UK life sciences commerical environment and HMG/ABPI collaboration in attracting investment |
| 19 May 2025 | Jonathan ReynoldsDBT | To discuss the Industrial Strategy |
| 14 May 2025 | Ashley DaltonDHSC | To engage with vaccines stakeholders on vaccine delivery |
| 6 May 2025 | Patrick VallanceDSIT | To discuss the pharmaceutical landscape in the UK |
| 2 April 2025 | Jonathan ReynoldsDBT | To discuss the policy environment for the life sciences sector in the UK |
| 2 April 2025 | Poppy GustafssonDBT | To discuss the UK life sciences commerical environment and investment in this sector |
| 31 March 2025 | Patrick VallanceDSIT | To discuss pharmaceuticals |
| 10 March 2025 | Jonathan ReynoldsDBT | To discuss the industrial strategy |
| 10 March 2025 | Sarah JonesDBT | To discuss the Industrial Strategy |
| 4 March 2025 | Douglas AlexanderDBT | To discuss the current trading environment |
| 11 February 2025 | Gillian MerronDHSC | To discuss how To make the UK a global leader in clinical research and life sciences |
| 3 December 2024 | Karin SmythDHSC | Attendance at ABPI Board meeting |
| 25 November 2024 | Jonathan ReynoldsDBT | To discuss advanced manufacturing |
| 24 October 2024 | Andrew GwynneDHSC | To discuss the Pandemic Accord. |
| 23 October 2024 | Karin SmythDHSC | Introductory meeting with the CEO |
| 22 October 2024 | Wes StreetingDHSC | To discuss life sciences and the UK's investment environment |
| 22 October 2024 | Peter KyleDSIT | To discuss priorities for the life sciences council and key issues for the sector. |
| 22 October 2024 | Patrick VallanceDSIT | Meeting of the Life Sciences Council. |
| 15 October 2024 | Mary CreaghDefra | To discuss perspecties on the use of Digital Sequencing Information on genetic resources, ahead of the Convention on Biological Diversity. |
| 10 October 2024 | Sarah JonesDBT | Discussed the development of the HMG Industrial Strategy and the Green Paper launch |
| 5 September 2024 | Patrick VallanceDSIT | To discuss alternatives to the use of animals in science |
| 3 September 2024 | Nick Thomas-SymondsCabinet Office | Meeting with the Domestic Advisory Group of stakeholders that Ministers meet on a regular basis as required under the UK-EU Trade and Cooperation Agreement. |
| 11 July 2024 | Gillian MerronDHSC | An introductory call about life sciences |
Consultant lobbying firms
- Shape Health Public Affairs LimitedJuly to September 2024; April to June 2024
